Fazeel M. Siddiqui

Fazeel M. Siddiqui

Auto-generated profile, based on publicly available information

Fazeel M. Siddiqui

Department of Neurology, University of Michigan Health-West, Wyoming (F.S.).

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Stroke
Verified
Journal Article
Closed access
FSFazeel M. Siddiqui
Fazeel M. Siddiqui
SDSudeepta Dandapat
Sudeepta Dandapat
CBChirantan Banerjee
Chirantan Banerjee
SZSusanna M. Zuurbier
Susanna M. Zuurbier
MJMark Johnson
Mark Johnson
JCJonathan M. Coutinho
Jonathan M. Coutinho
Background and Purpose—: Cerebral venous thrombosis is generally treated with anticoagulation. However, some patients do not respond to medical therapy and these might benefit from mechanical thrombectomy. The aim of this study was to gain a better understanding of the efficacy and safety of mechanical thrombectomy in patients with cerebral venous thrombosis, by performing a systematic review of the literature. Methods—: We identified studies published between January 1995 and February 2014 from PubMed and Ovid. We included all cases of cerebral venous thrombosis in whom mechanical thrombectomy was performed with or without intrasinus thrombolysis. Good outcome was defined as normal or mild neurological deficits at discharge (modified Rankin Scale, 0–2). Secondary outcome variables included periprocedural complications and recanalization rates. Results—: Our study included 42 studies (185 patients). Sixty percent of patient had a pretreatment intracerebral hemorrhage and 47% were stuporous or comatose. AngioJet was the most commonly used device (40%). Intrasinus thrombolysis was used in 131 patients (71%). Overall, 156 (84%) patients had a good outcome and 22 (12%) died. Nine (5%) patients had no recanalization, 38 (21%) had partial, and 137 (74%) had near to complete recanalization. The major periprocedural complication was new or increased intracerebral hemorrhage (10%). The use of AngioJet was associated with lower rate of complete recanalization (odds ratio, 0.2; 95% confidence interval, 0.09–0.4) and lower chance of good outcome (odds ratio, 0.5; 95% confidence interval, 0.2–1.0). Conclusions—: Our systematic review suggests that mechanical thrombectomy is reasonably safe but controlled studies are required to provide a definitive answer on its efficacy and safety in patients with cerebral venous thrombosis.

1 January 2014 in Interventional Neuroradiology
Verified
Journal Article
Closed access
FSFazeel M. Siddiqui
Fazeel M. Siddiqui
CBChirantan Banerjee
Chirantan Banerjee
SZSusanna M. Zuurbier
Susanna M. Zuurbier
QHQing Hao
Qing Hao
CAChul Ahn
Chul Ahn
JSJan Stam
Jan Stam
Small retrospective studies have shown the benefit of endovascular treatment with intrasinus thrombolysis (IST) or mechanical thrombectomy (MT) with/without IST (MT+/−IST) in cases of multifocal cerebral venous thrombosis (CVT). Our study compares the mortality, functional outcome and periprocedural complications among patients treated with MT +/– IST versus IST alone. We reviewed clinical and angiographic findings of 63 patients with CVT who received endovascular treatment at three tertiary care centers. Primary outcome variables were discharge mortality and neurological dysfunction, and intermediate (three months) and long-term (>six months) morbidity. The modified Rankin scale (mRS) was used to assess morbidity. mRS ≤1 was considered a good recovery. Neurological dysfunction was rated as neuroscore: 0, normal; 1, mild (ambulatory, communicative); 2, moderate (non-ambulatory, communicative); and 3, severe (non-ambulatory, non-communicative/comatose). In patients who received IST alone, presenting neurological deficits were comparatively minor (p<0.001). When the two groups were adjusted for admission neuroscore, there was no statistical significance between discharge mortality [7(21%) versus 4(14%), p=0.228], neurological dysfunction (p=0.442), intermediate (p=0.336) and long-term morbidity (p=0.988). Patients who received MT +/- IST had a higher percentage of periprocedural complications without reaching statistical significance. Compared to IST, MT was performed in severe cases with extensive sinus involvement. When adjusted for admission neurological dysfunction, both groups had similar mortality and discharge neurological dysfunction and similar intermediate and long-term morbidity.

1 August 2017 in Stroke
Verified
Journal Article
Closed access
PDF file
FSFazeel M. Siddiqui
Fazeel M. Siddiqui
CLCarl D. Langefeld
Carl D. Langefeld
CMCharles J. Moomaw
Charles J. Moomaw
MCMary E. Comeau
Mary E. Comeau
PSPadmini Sekar
Padmini Sekar
DWDaniel Woo
Daniel Woo
Background and Purpose—: Statin use may be associated with improved outcome in intracerebral hemorrhage patients. However, the topic remains controversial. Our analysis examined the effect of prior, continued, or new statin use on intracerebral hemorrhage outcomes using the ERICH (Ethnic/Racial Variations of Intracerebral Hemorrhage) data set. Methods—: We analyzed ERICH (a multicenter study designed to examine ethnic variations in the risk, presentation, and outcomes of intracerebral hemorrhage) to explore the association of statin use and hematoma growth, mortality, and 3-month disability. We computed subset analyses with respect to 3 statin categories (prior, continued, or new use). Results—: Two thousand four hundred and fifty-seven enrolled cases (mean age, 62 years; 42% females) had complete data on mortality and 3-month disability (modified Rankin Scale). Among those, 1093 cases were on statins (prior, n=268; continued, n=423; new, n=402). Overall, statin use was associated with reduced mortality and disability without any effect on hematoma growth. This association was primarily driven by continued/new statin use. A multivariate analysis adjusted for age and major predictors for poor outcome showed that continued/new statins users had good outcomes compared with prior users. However, statins may have been continued/started more frequently among less severe patients. When a propensity score was developed based on factors that could influence a physician’s decision in prescribing statins and used as a covariate, continued/new statin use was no longer a significant predictor of good outcome. Conclusions—: Although statin use, especially continued/new use, was associated with improved intracerebral hemorrhage outcomes, this effect may merely reflect the physician’s view of a patient’s prognosis rather than a predictor of survival.

1 June 2019 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
FSFazeel M. Siddiqui
Fazeel M. Siddiqui
MWMatthew W. Weber
Matthew W. Weber
SDSudeepta Dandapat
Sudeepta Dandapat
SSSteve Scaife
Steve Scaife
MBMichael Buhnerkempe
Michael Buhnerkempe
JCJonathan M. Coutinho
Jonathan M. Coutinho

1 August 2018 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
ZRZachary Rosenfeldt
Zachary Rosenfeldt
KCKatelyn Conklen
Katelyn Conklen
BJBreck Jones
Breck Jones
DFDon Ferrill
Don Ferrill
MDMaithili Deshpande
Maithili Deshpande
FSFazeel M. Siddiqui
Fazeel M. Siddiqui

8 February 2021 in International Journal of Stroke
Verified
Journal Article
Closed access
PDF file
KUKiddy L Ume
Kiddy L Ume
SDSudeepta Dandapat
Sudeepta Dandapat
MWMatthew W Weber
Matthew W Weber
CZCynthia B Zevallos
Cynthia B Zevallos
AFAmber Fifer
Amber Fifer
FSFazeel M Siddiqui
Fazeel M Siddiqui
The hyperdense middle cerebral artery sign on computed tomography indicates proximal middle cerebral artery occlusion. Recent reports suggest an association between the hyperdense sign and successful reperfusion. The prognostic value of the hyperdense middle cerebral artery sign in patients receiving mechanical thrombectomy has not been extensively studied. Our study aims to evaluate the association between the hyperdense middle cerebral artery sign and functional outcome in patients with M1 occlusions that had undergone mechanical thrombectomy. We conducted a single-center retrospective observational cohort study of 102 consecutive patients presenting with acute M1 occlusions that had undergone mechanical thrombectomy. Patients were stratified into cohorts based on the presence of hyperdense middle cerebral artery sign visually assessed on computed tomography by two readers. The outcomes of interests were functional disability measured by the ordinal Modified Rankin Scale (mRS) at 90 days, mortality, reperfusion status and hemorrhagic conversion. Out of the 102 patients with M1 occlusions, 71 had hyperdense middle cerebral artery sign. There was no significant difference between the cohorts in age, baseline mRS, NIHSS, ASPECTS, and time to reperfusion. The absence of hyperdense middle cerebral artery sign was associated with increased odds of being dependent or dying (higher mRS) (OR: 3.24, 95% CI: 1.30–8.06, p = 0.011) after adjusting for other significant predictors, including age, female sex, hypertension, presenting serum glucose, ASPECTS, CTA collateral score, and successful reperfusion. The absence of hyperdense middle cerebral artery sign is associated with worse functional outcome in patients presenting with M1 occlusions undergoing thrombectomy.